Independent DSMC Has Completed Its Second, Pre-Planned Interim Analysis In Ongoing Oval Phase 3 Study
12/08/2020 13:29
Aug 12 (Reuters) - Vascular Biogenics Ltd VBLT.O :
* VASCULAR BIOGENICS LTD - INDEPENDENT DSMC HAS COMPLETED
ITS
SECOND, PRE-PLANNED INTERIM ANALYSIS IN ONGOING OVAL PHASE 3
STUDY
* VASCULAR BIOGENICS LTD - DSMC UNANIMOUSLY RECOMMENDED THAT
STUDY
CONTINUE AS PLANNED.
* VASCULAR BIOGENICS LTD - NEXT DSMC REVIEW IN OVAL STUDY IS
EXPECTED IN Q1 OF 2021.
Source text for Eikon: ID:nGNX2QxHhN
Further company coverage: VBLT.O
(((Reuters.Briefs@thomsonreuters.com);))
Recent news on Notable Labs
See all newsUS STOCKS-Wall St ends sharply lower following Trump's anti-Powell tirade
US STOCKS-Wall St ends sharply lower amid Trump's tirade against Fed's Powell
US STOCKS-Wall St tumbles as Trump ramps up tirade against Fed's Powell
Brief: Notable Labs Says Co, Units Filed Voluntary Petition Under Provisions Of Chapter 7 Of Title 11 Of US Bankruptcy Code
Brief: Notable Labs Approved A Streamlined Operating Plan Which Includes Exploring Strategic Alternatives